HS OBTAIN

Free

Rating summary

Details

Released
Updated
Version
Compatibility
Age Rating
Size
Devices
Data updated
Languages

November 3, 2023
September 30, 2024
1.2.71
iOS 12.0+
17+
153.92MB
iPhone, iPad, iPod
5 months ago
47

Features

macOS Compatibility

Developer

Hello Thread

✨Promote your app ✨

📝2+ tags

Tags↘︎

🔄6+ apps

Alternatives↘︎

📦w/o updates

Updates frequency↘︎

🖼️Get Icon

Icons↘︎

About

This is the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.

What's New in HS OBTAIN

1.2.71

September 30, 2024

iOS 18 compatibility

Alternatives

Empatica Care

by Empatica

(9)

HS OBTAIN vs Empatica Care

0 / 3.3Score

SHSA Conference

HS OBTAIN vs SHSA 2025

0 / 0Score

Clinical Ink Engage (EU)

by Clinical Ink, Inc

(11)

HS OBTAIN vs Clinical Ink Engage (EU)

0 / 3.1Score

Teletherapy by Easy EMDR

Secure, Accessible Teletherapy

(3)

In-App Purchases

HS OBTAIN vs Teletherapy by Easy EMDR

0 / 5Score

no / yesIn-App Purchase

HSR Patients App

by swiss4ward Europe S.L.

HS OBTAIN vs HSR Patients App

0 / 0Score

MoonLake M1095-HS-301/302

by ERT,INC

HS OBTAIN vs MoonLake M1095

0 / 0Score

See similar apps

Developer apps

The Duchenne Registry

Duchenne Muscular Dystrophy

(5)

IED Log

A study about angry outbursts

HELIOS-A

HELIOS-A research study app